Cargando…

Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review

BACKGROUND: Hepatocellular carcinoma (HCC) accounts for more than 85%-90% of primary liver cancer globally, and approximately 45% of deaths from HCC occur in greater China. This disease poses a significant economic burden for patients, payers and society and significantly affects patients' qual...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Huimin, Li, Meng, Lei, Qing, Luo, Zejun, Xue, Yan, Yao, Dongning, Lai, Yunfeng, Ung, Carolina Oi Lam, Hu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068962/
https://www.ncbi.nlm.nih.gov/pubmed/35530735
http://dx.doi.org/10.3389/fpubh.2022.801981
_version_ 1784700332443435008
author Zou, Huimin
Li, Meng
Lei, Qing
Luo, Zejun
Xue, Yan
Yao, Dongning
Lai, Yunfeng
Ung, Carolina Oi Lam
Hu, Hao
author_facet Zou, Huimin
Li, Meng
Lei, Qing
Luo, Zejun
Xue, Yan
Yao, Dongning
Lai, Yunfeng
Ung, Carolina Oi Lam
Hu, Hao
author_sort Zou, Huimin
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) accounts for more than 85%-90% of primary liver cancer globally, and approximately 45% of deaths from HCC occur in greater China. This disease poses a significant economic burden for patients, payers and society and significantly affects patients' quality of life (QoL). However, such impact of HCC in greater China has not been well characterized. This review was conducted to analyze the current evidence about the economic and humanistic impact of HCC in greater China for informing national disease management and identifying clinical gaps yet to be resolved. METHODS: A systematic search literature using seven databases (Web of Science, PubMed, Medline, Cochrane Central, China National Knowledge Infrastructure, Wanfang, and Weipu) was performed to identify interventional and observational studies that reported the impact of HCC on cost or QoL and published before April 6, 2021. The focus population included adult patients with HCC in greater China. This review excluded any studies that focused on any specific treatment. Study quality was assessed using the Effective Public Health Practice Project tool. RESULTS: Of 39,930 studies retrieved, 27 were deemed eligible for inclusion. The methodologies, perspectives and data sources used in studies were heterogeneous. In greater China, while few studies reported the health expenditures of HCC patients and investigations about economic burden at national level was lacking, the significant economic impact of HCC on patients and their families had been reported. Health-related costs increased as the disease deteriorated. Additionally, HCC also has a negative impact on the QoL of patients, mostly in terms of physical, cognitive, social functioning and severe symptoms. CONCLUSIONS: HCC has brought significant economic and QoL burden to patients in greater China. Both physical and psychological factors predicted QoL in patients with HCC in greater China. Future studies should explore the disease-related economic effects on Chinese patients and their families, the effects of physical and psychological factors on QoL and the relationships of physical and psychological factors in the region. Systematic Review Registration: www.crd.york.ac.uk/prospero/display_record.php?RecordID=278421, PROSPERO: CRD42021278421
format Online
Article
Text
id pubmed-9068962
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90689622022-05-05 Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review Zou, Huimin Li, Meng Lei, Qing Luo, Zejun Xue, Yan Yao, Dongning Lai, Yunfeng Ung, Carolina Oi Lam Hu, Hao Front Public Health Public Health BACKGROUND: Hepatocellular carcinoma (HCC) accounts for more than 85%-90% of primary liver cancer globally, and approximately 45% of deaths from HCC occur in greater China. This disease poses a significant economic burden for patients, payers and society and significantly affects patients' quality of life (QoL). However, such impact of HCC in greater China has not been well characterized. This review was conducted to analyze the current evidence about the economic and humanistic impact of HCC in greater China for informing national disease management and identifying clinical gaps yet to be resolved. METHODS: A systematic search literature using seven databases (Web of Science, PubMed, Medline, Cochrane Central, China National Knowledge Infrastructure, Wanfang, and Weipu) was performed to identify interventional and observational studies that reported the impact of HCC on cost or QoL and published before April 6, 2021. The focus population included adult patients with HCC in greater China. This review excluded any studies that focused on any specific treatment. Study quality was assessed using the Effective Public Health Practice Project tool. RESULTS: Of 39,930 studies retrieved, 27 were deemed eligible for inclusion. The methodologies, perspectives and data sources used in studies were heterogeneous. In greater China, while few studies reported the health expenditures of HCC patients and investigations about economic burden at national level was lacking, the significant economic impact of HCC on patients and their families had been reported. Health-related costs increased as the disease deteriorated. Additionally, HCC also has a negative impact on the QoL of patients, mostly in terms of physical, cognitive, social functioning and severe symptoms. CONCLUSIONS: HCC has brought significant economic and QoL burden to patients in greater China. Both physical and psychological factors predicted QoL in patients with HCC in greater China. Future studies should explore the disease-related economic effects on Chinese patients and their families, the effects of physical and psychological factors on QoL and the relationships of physical and psychological factors in the region. Systematic Review Registration: www.crd.york.ac.uk/prospero/display_record.php?RecordID=278421, PROSPERO: CRD42021278421 Frontiers Media S.A. 2022-04-21 /pmc/articles/PMC9068962/ /pubmed/35530735 http://dx.doi.org/10.3389/fpubh.2022.801981 Text en Copyright © 2022 Zou, Li, Lei, Luo, Xue, Yao, Lai, Ung and Hu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Zou, Huimin
Li, Meng
Lei, Qing
Luo, Zejun
Xue, Yan
Yao, Dongning
Lai, Yunfeng
Ung, Carolina Oi Lam
Hu, Hao
Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review
title Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review
title_full Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review
title_fullStr Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review
title_full_unstemmed Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review
title_short Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review
title_sort economic burden and quality of life of hepatocellular carcinoma in greater china: a systematic review
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068962/
https://www.ncbi.nlm.nih.gov/pubmed/35530735
http://dx.doi.org/10.3389/fpubh.2022.801981
work_keys_str_mv AT zouhuimin economicburdenandqualityoflifeofhepatocellularcarcinomaingreaterchinaasystematicreview
AT limeng economicburdenandqualityoflifeofhepatocellularcarcinomaingreaterchinaasystematicreview
AT leiqing economicburdenandqualityoflifeofhepatocellularcarcinomaingreaterchinaasystematicreview
AT luozejun economicburdenandqualityoflifeofhepatocellularcarcinomaingreaterchinaasystematicreview
AT xueyan economicburdenandqualityoflifeofhepatocellularcarcinomaingreaterchinaasystematicreview
AT yaodongning economicburdenandqualityoflifeofhepatocellularcarcinomaingreaterchinaasystematicreview
AT laiyunfeng economicburdenandqualityoflifeofhepatocellularcarcinomaingreaterchinaasystematicreview
AT ungcarolinaoilam economicburdenandqualityoflifeofhepatocellularcarcinomaingreaterchinaasystematicreview
AT huhao economicburdenandqualityoflifeofhepatocellularcarcinomaingreaterchinaasystematicreview